Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Product Categories
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.
4-hydroxy Diclofenac is an active metabolite of the non-steroidal anti-inflammatory drug (NSAID) and COX inhibitor diclofenac (Item Nos. 70680 | 22983).1 It is formed from diclofenac by the cytochrome P450 (CYP) isoform CYP2C9 in human liver microsomes.2 4-hydroxy Diclofenac inhibits COX activity (IC50 = 32 nM) and reduces prostaglandin E2 (PGE2; Item No. 14010) production (IC50 = 17 nM) in isolated human rheumatoid synovial cells.3
WARNING This product is not for human or veterinary use.
1. Analysis of diclofenac and four of its metabolites in human urine by HPLC. Pharm. Res. 12(5), 756-762 (1995).
2. The role of CYP2C9 genotype in the metabolism of diclofenac in vivo and in vitro. Eur. J. Clin. Pharmacol. 57(10), 729-735 (2001).
3. Hydrolytic activity is essential for aceclofenac to inhibit cyclooxygenase in rheumatoid synovial cells. J. Pharmacol. Exp. Ther. 289(2), 676-681 (1999).
Generation of HepG2 cells with high expression of multiple drug-
Inhibition of drug-